Skip to content

A Study on the Efficacy of Bridge Dry Swallowing for Gastroesophageal Reflux Disease

A Study on the Efficacy of Bridge Dry Swallowing for Gastroesophageal Reflux Disease: Randomised controlled trial - BRIDGE Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059650
Enrollment
48
Registered
2025-11-05
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux

Interventions

In addition to lifestyle guidance, participants will perform dry swallowing in the anti-gravity esophageal position (bridge position) 10 times per day for 4 weeks. Lifestyle guidance

Sponsors

Kansai Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with GERD symptoms and an FSSG (Frequency Scale for the Symptoms of GERD) score of more than 8. Outpatients or inpatients in whom diseases other than GERD have been ruled out by EGD (esophagogastroduodenoscopy). Patients with preserved cognitive function sufficient to fully understand the study outline and training procedure. Patients who have provided written informed consent.

Exclusion criteria

Exclusion criteria: Patients who have difficulty assuming the bridge (hip-raised) position due to low back pain or other conditions. Patients with severe dysphagia who are unable to swallow saliva. Pregnant women or those who may be pregnant. Patients with Los Angeles classification grade C or D esophagitis. Patients taking acid-suppressing medications (PPI, P-CAB, H2-receptor antagonists), mosapride, rikkunshito, or aluminum hydroxide gel at the time of consent. Patients with severe hiatal hernia who are considered to be at high risk of aspiration pneumonia due to regurgitation or vomiting. Any other patients deemed inappropriate for inclusion by the principal investigator or subinvestigators.

Design outcomes

Primary

MeasureTime frame
FSSG (Frequency Scale for the Symptoms of GERD) questionnaire at 4-week follow-up

Secondary

MeasureTime frame
Upper Gastrointestinal Endoscopy

Countries

Japan

Contacts

Public ContactKenjiro Kunieda

Kansai Medical University Department of Physical Medicine and Rehabilitation

ken2rou.k@gmail.com072-843-3364

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026